This document is a publication of a European patent application (EP4269442A1) for a mesothelin binding molecule and its application, filed by Zhejiang Nanomab Technology Center Co. Ltd. The publication date is March 11, 2026. The application includes various International Patent Classification (IPC) codes related to peptides, molecular biology, and medical applications.

As this is a patent application publication, it does not impose direct compliance obligations on regulated entities. However, it is relevant for companies operating in the pharmaceutical and biotechnology sectors, particularly those involved in cancer therapeutics or diagnostics, as it pertains to intellectual property rights and potential future market exclusivity. Companies should monitor the progress of this patent application through the EPO.